Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in IIPs: Secondary analysis of SETUP trial T. Arai (Sakai, Japan), H. Kida (Toyonaka, Japan), Y. Ogata (Hiroshima, Japan), S. Marumo (Osaka, Japan), H. Matsuoka (Habikino, Japan), I. Ghoma (Sakai, Japan), M. Mori (Toyonaka, Japan), Y. Suguru (Ichinomiya, Japan), K. Tachibana (Sakai, Japan), C. Sugimoto (Sakai, Japan), M. Akira (Sakai, Japan), Y. Inoue (Sakai, Japan)
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Arai (Sakai, Japan), H. Kida (Toyonaka, Japan), Y. Ogata (Hiroshima, Japan), S. Marumo (Osaka, Japan), H. Matsuoka (Habikino, Japan), I. Ghoma (Sakai, Japan), M. Mori (Toyonaka, Japan), Y. Suguru (Ichinomiya, Japan), K. Tachibana (Sakai, Japan), C. Sugimoto (Sakai, Japan), M. Akira (Sakai, Japan), Y. Inoue (Sakai, Japan). Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in IIPs: Secondary analysis of SETUP trial. 1927
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020 Year: 2021
Acute exacerbation in patients with bronchiectasis: What prognostic factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016
Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial Source: Eur Respir J, 51 (4) 1701389; 10.1183/13993003.01389-2017 Year: 2018
Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in Japan Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011
Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort Source: Eur Respir J, 53 (5) 1801925; 10.1183/13993003.01925-2018 Year: 2019
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
Incidence of multiple progression events in patients with idiopathic pulmonary fibrosis (IPF) in the pooled CAPACITY and ASCEND trials Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016
Procalcitonin as a predictor of pneumonia in patients hospitalized with acute exacerbation of COPD: a prospective observational study Source: International Congress 2017 – COPD biomarkers Year: 2017
Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study Source: Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017 Year: 2018
Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies. Source: International Congress 2017 – Pulmonary embolism Year: 2017
Effect of pirfenidone on treatment-emergent (TE) all-cause mortality (ACM) in patients with idiopathic pulmonary fibrosis (IPF): Pooled data analysis from ASCEND and CAPACITY Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015
Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial Source: International Congress 2018 – COPD management Year: 2018
Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005
Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008